| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.009 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |